Growth Metrics

Gilead Sciences (GILD) Other Non-Current Liabilities (2016 - 2025)

Gilead Sciences (GILD) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities fell 10.04% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Dec 2025, down 10.04%, and an annual FY2025 reading of $1.2 billion, down 10.04% over the prior year.
  • Other Non-Current Liabilities was $1.2 billion for Q4 2025 at Gilead Sciences, up from $866.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.9 billion in Q2 2022 and bottomed at $341.0 million in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $1.4 billion, with a median of $1.2 billion recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities crashed 80.84% in 2021, then skyrocketed 299.89% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $976.0 million in 2021, then increased by 20.8% to $1.2 billion in 2022, then increased by 8.57% to $1.3 billion in 2023, then rose by 1.17% to $1.3 billion in 2024, then decreased by 10.04% to $1.2 billion in 2025.
  • Business Quant data shows Other Non-Current Liabilities for GILD at $1.2 billion in Q4 2025, $866.0 million in Q3 2025, and $859.0 million in Q2 2025.